Here is a summary of our April, 2012 Quick Question: The US FDA is planning guidelines for regulating laboratory-developed tests (LDTs). What plans have you made in response? a. We are discontinuing all LDTs: 3 (15%) b. We didn’t know this is happening: 11 (55%) c. None, this will only apply to reference laboratory LDTs: 1 (5%) […]

On October 21 I posted my